Gershman et al identified predictors affecting mortality in patients with renal cell carcinoma. This can help to identify patients who may benefit from more aggressive or novel therapy. The authors are from Rhode Island Hospital, Miriam Hospital, University of Illinois, and the Mayo Clinic Rochester.